...
首页> 外文期刊>Journal of Medicinal Chemistry >Novel gamma-aminobutyric acid rho(1) receptor antagonists; Synthesis, pharmacological activity and structure-activity relationships
【24h】

Novel gamma-aminobutyric acid rho(1) receptor antagonists; Synthesis, pharmacological activity and structure-activity relationships

机译:新型γ-氨基丁酸rho(1)受体拮抗剂;合成,药理活性和构效关系

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

gamma-Aminobutyric acid (GABA) analogues based on 4-amino-cyclopent-1-enyl phosphinic acid (34-42) and 3-aminocyclobutane phosphinic acids (51, 52, 56, 57) were investigated in order to obtain selective homomeric rho(1) GABA(C) receptor antagonists. The effect of the stereochemistry and phosphinic acid substituent of these compounds on potency and selectivity within the GABA receptor subtypes was investigated. Compounds of high potency at GABA(C) rho(1) receptors (36, K-B = 0.78 mu M) and selectivity greater than 100 times (41, K-B = 4.97 mu M) were obtained. The data obtained was analyzed along with the known set of GABA(C) rho(1) receptor-ligands, leading to the development of a pharmacophore model for this receptor, which can be used for in silico screening.
机译:研究了基于4-氨基-环戊-1-烯基次膦酸(34-42)和3-氨基环丁烷次膦酸(51、52、56、57)的γ-氨基丁酸(GABA)类似物,以获得选择性的同型铑(1)GABA(C)受体拮抗剂。研究了这些化合物的立体化学和次膦酸取代基对GABA受体亚型内效能和选择性的影响。获得了对GABA(C)rho(1)受体具有高效力的化合物(36,K-B = 0.78μM),并且选择性大于100倍(41,K-B = 4.97μM)。将获得的数据与已知的一组GABA(C)rho(1)受体-配体一起进行分析,从而开发了该受体的药效团模型,该模型可用于计算机筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号